DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Doody RS, Thomas RG, Farlow M. , et al; Alzheimer's Disease Cooperative Study Steering Committee; Solanezumab Study Group.
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
N Engl J Med 2014;
370 (04) 311-321
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.